investordatabase.org

Frazier Life Sciences Management, LP

frazierls.com Direct investor

Frazier Life Sciences is a biotech investment firm managing venture capital and public equity strategies. It invests in and builds product-focused companies developing novel therapeutics, from seed stage to public companies.

Frazier Life Sciences Management, LP is a venture capital firm headquartered in Palo Alto, United States. It invests directly in companies, from seed to growth, in biotech, therapeutics and pharmaceuticals. $6.9B+ under management, as it reports.

“Frazier Life Sciences is a longstanding biotech investment firm with venture and public strategies partnering with and building companies developing novel therapeutics.”

— Frazier Life Sciences Management, LP, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Growth
Headquarters
Palo Alto, United States
Invests in
US
Sectors
biotech, therapeutics, pharmaceuticals
Assets under management
$6.9B+

Team, as Frazier Life Sciences Management, LP publishes it

  • Albert Cha Managing Partner
  • James N. Topper Managing Partner
  • Patrick Heron Managing Partner
  • Daniel Estes General Partner
  • James W. Brush General Partner and Portfolio Manager
  • Aditya Kohli Partner
  • Anna H. Chen Partner
  • Joe Cabral Partner
  • Kevin Li Partner
  • Angel Martin Vice President
  • Kiah Williams Vice President
  • Lin Mu Vice President

Names and roles exactly as listed on frazierls.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 53 co-investors found.

  • RA Capital Management 10 shared companies: hillevax.com, alentis.ch, angitiabio.com, arcutis.com…
  • OrbiMed 10 shared companies: alentis.ch, aspenneuroscience.com, discmedicine.com, angitiabio.com…
  • Aisling Capital Management LP 6 shared companies: veronapharma.com, bridgebio.com, chimerix.com, gondolabio.com…
  • Longitude Capital 6 shared companies: alentis.ch, campfieldtx.com, mirumpharma.com, collegiumpharma.com…
  • Avoro Capital Advisors LLC 6 shared companies: acerta-pharma.com, aviditybiosciences.com, scorpiontx.com, amicusrx.com…
  • Bain Capital Life Sciences 6 shared companies: newamsterdampharma.com, discmedicine.com, angitiabio.com, arcutis.com…
  • Atlas Venture 5 shared companies: diagonaltx.com, discmedicine.com, vimatx.com, akerotx.com…
  • EcoR1 Capital 5 shared companies: diagonaltx.com, scorpiontx.com, collegiumpharma.com, bridgebio.com…
  • Viking Global Investors LP 5 shared companies: star-therapeutics.com, bridgebio.com, architecttherapeutics.com, gondolabio.com…
  • venBio Partners LLC 4 shared companies: veronapharma.com, parabilismed.com, akerotx.com, 35pharma.com

and 43 more — the graph.

Where this comes from

Every fact above was read from a page Frazier Life Sciences Management, LP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 5297 · added 2026-09-03 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under